Related Experiment Video

Updated: Mar 10, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.5K

The Emerging Role of Cdk5 in Cancer

Karine Pozo1, James A Bibb2

  • 1Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX USA; Department of Surgery, The University of Texas Southwestern Medical Center, Dallas, TX USA.

Trends in Cancer
|December 6, 2016
PubMed

Insights

Cyclin-dependent kinase 5 (Cdk5) drives cancer growth and spread, offering a new target for anti-cancer therapies. Targeting Cdk5 and its pathways may overcome treatment resistance and improve cancer outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinase 5 (Cdk5) is primarily known for its functions in the central nervous system.
  • Emerging evidence links Cdk5 to the development and progression of various cancers, including breast, lung, colon, pancreatic, melanoma, thyroid, and brain tumors.

Purpose of the Study:

  • To review the role of Cdk5 in cancer development, progression, and chemoresistance.
  • To discuss current and novel strategies for targeting Cdk5 as an anti-cancer therapeutic approach.

Main Methods:

  • Literature review of studies investigating Cdk5's role in cancer.
  • Analysis of molecular mechanisms underlying Cdk5-driven tumorigenesis.
  • Evaluation of therapeutic strategies targeting Cdk5.

Main Results:

  • Cdk5 contributes to tumor growth, proliferation, and metastasis.
  • Cdk5 is implicated in conferring resistance to chemotherapy.
  • Cdk5's broad pro-tumorigenic functions highlight its potential as a drug target.

Conclusions:

  • Cdk5 plays a significant role in multiple cancer types, promoting key oncogenic processes.
  • Targeting Cdk5 and its downstream pathways presents a promising strategy for developing novel cancer therapies.
  • Further research into Cdk5 inhibition could lead to improved treatment outcomes and overcome drug resistance.
Keywords:
Cdk5cancerresistance

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.8K